Aubrey Rankin - Mar 15, 2022 Form 4 Insider Report for Revance Therapeutics, Inc. (RVNC)

Role
Director
Signature
/s/ Dwight Moxie, Attorney-in-Fact
Stock symbol
RVNC
Transactions as of
Mar 15, 2022
Transactions value $
-$21,664
Form type
4
Date filed
3/17/2022, 05:50 PM
Previous filing
Dec 6, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RVNC Common Stock Tax liability -$21.7K -1.37K -1.44% $15.79 94.1K Mar 15, 2022 Direct F1
holding RVNC Common Stock 154K Mar 15, 2022 The Rankin Irrevocable Trust F2
holding RVNC Common Stock 322K Mar 15, 2022 Aubrey and Luanne Rankin Revocable Living Trust Dated July 1, 2009 F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares withheld by and surrendered to the Issuer on March 15, 2022, to satisfy tax withholding obligations that arose in connection with the vesting of Restricted Stock award (the "RSA") for 11,905 shares. The RSA vests in three equal annual installments from March 15, 2021, subject to Mr. Rankin's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) on each vesting date.
F2 These shares are held by The Rankin Irrevocable Trust. Mr. Rankin is a Trustee of the Rankin Irrevocable Trust.
F3 These shares are held by the Aubrey and Luanne Rankin Revocable Living Trust dated July 1, 2009. Mr. Rankin is a Trustee of this Trust.